A case of high-risk AML in a patient with advanced systemic mastocytosis.
Clin Case Rep
; 11(7): e7134, 2023 Jul.
Article
en En
| MEDLINE
| ID: mdl-37469366
ABSTRACT
Aggressive SM + AML has limited therapeutic options. Even a strong combination of decitabine-venetoclax-midostaurin has a transient effect on AML and a mitigated effect on SM. Larger series are required to identify the best therapeutic strategy.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Clin Case Rep
Año:
2023
Tipo del documento:
Article